Status: Recruiting
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
This study will evaluate a cellular, acellular, matrix-like product (CAMP) and Standard of Care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs). The study will evaluate Amnio-Maxx® Dual Layer Amnion Patch.
Participants needed: 248
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Royal BiologicsUpdated: Oct 7, 2025Locations: 8
Eligibility criteria
The potential subject is 18 years of age or older. At least 50% of the enrolled... [+8]
The Subject has a known life expectancy of < 1 year. [+16]